Activation of this pathway enhances DNA damage repair, apoptosis evasion, and cell cycle recovery thereby reducing cisplatin response in cancer cells.[110] METTL3 upregulation is associated with carboplatin resistance in ovarian cancer via activation of cAMP‐dependent signaling. This evidence concerns the gene METTL3 and cancer.